ACVC Premium Access

Dual or triple antithrombotic therapy?

Event: Acute Cardiovascular Care 2019

Topic: Clinical

Session type: Debate Session

Date: 4 March 2019

Time: 11:00 - 12:30

Session

6 presentations in this session

Positioning of the topic - DAT for all ACS patients with atrial fibrillation receiving coronary stents

Speaker: Professor K. Huber (Vienna, AT)

Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - PRO

Speaker: Doctor A. Sambola (Barcelona, ES)

Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - CONTRA

Speaker: Doctor A. Rubboli (Ravenna, IT)

Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Rebuttal

Speaker: Doctor A. Rubboli (Ravenna, IT)

Speaker: Doctor A. Sambola (Barcelona, ES)

Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Moderated discussion.

Speaker: Professor K. Huber (Vienna, AT)

Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Conclusion.

Speaker: Professor P. Clemmensen (Hamburg, DE)

Thumbnail

7 speakers from this session

Professor Kurt Huber

Wilhelminen Hospital, Vienna (Austria)

37 presentations

0 follower

Doctor Antonia Sambola

University Hospital Vall d'Hebron, Barcelona (Spain)

7 presentations

0 follower

Doctor Andrea Rubboli

Santa Maria delle Croci Hospital, Ravenna (Italy)

10 presentations

0 follower

Doctor Andrea Rubboli

Santa Maria delle Croci Hospital, Ravenna (Italy)

10 presentations

0 follower

Doctor Antonia Sambola

University Hospital Vall d'Hebron, Barcelona (Spain)

7 presentations

0 follower

Professor Kurt Huber

Wilhelminen Hospital, Vienna (Austria)

37 presentations

0 follower

Professor Peter Michael Clemmensen

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

8 presentations

0 follower

This platform is supported by

logo Novo Nordisk